Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models (Q40433679)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models |
scientific article |
Statements
1 reference
Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models (English)
1 reference
Debra Ferguson
1 reference
Luis E Rodriguez
1 reference
Joann P Palma
1 reference
Marion Refici
1 reference
Kenneth Jarvis
1 reference
Jacqueline O'Connor
1 reference
Gerard M Sullivan
1 reference
David Frost
1 reference
Kennan Marsh
1 reference
Joy Bauch
1 reference
Haiying Zhang
1 reference
Nan-Horng Lin
1 reference
Saul Rosenberg
1 reference
Hing L Sham
1 reference
Ingrid B J K Joseph
1 reference
1 April 2005
1 reference
1 reference
Identifiers
1 reference